¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickel cell disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    ½Òº´, °¢±âº´
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • Ritter¡¯s disease
    ¸®Åͺ´
  • rolling disease
    ȸÀüº´
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • Schilder disease
    ½Ç´õº´
  • storage disease
    ÃàÀûº´
  • systemic disease
    Àü½Åº´
  • secondary disease
    ¼Ó¹ßº´, ¼Ó¹ßÁúȯ
  • self-limited disease
    ÀڱⱹÇѺ´
  • septic disease
    ÆÐÇ÷º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • valvular heart disease
    ÆÇ¸·½ÉÀ庴
  • vascular disease
    Ç÷°üº´
  • venereal disease
    ¼ºº´
  • veno-occlusive disease
    Á¤¸ÆÆó¼âº´
  • viral disease
    ¹ÙÀÌ·¯½ºº´
  • wasting disease
    ¼Ò¸ðº´
  • white-spot disease
    ¹é»öÁ¡º´
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • tracer disease method
    ÃßÀûÁúº´¹æ¹ý
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
  • acantholytic cell
    °¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acidophilic cell
    È£»ê¼º¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • acinic cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • inner cell mass
    ³»¼¼Æ÷A(Ò®á¬øàÎÔ).
  • inner cell mass (embryoblast)
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner cell mass embryoblast
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷(Ò®êáÙ¾á¬øà).
  • inner hair cell
    ¼ÓÅм¼Æ÷
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷
  • inner phalangeal cell
    ¼Ó¼Õ°¡¶ô¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷(¡­á¬øà).
  • inner pillar cell
    ¼Ó±âµÕ¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷
  • inner sustentacular cell
    ¼Ó¹öÆÀ¼¼Æ÷
  • insulin secreting islet cell tumor
    Àν¶¸° ºÐºñ¼º µµ¼¼Æ÷Á¾¾ç.
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • disease, Thornwaldts
    Àεγ¶¿°
  • disease, allergic
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • disease, autoimmune inner ear
    ÀÚ°¡¸é¿ª¼º ³»ÀÌÁúȯ
  • disease, gastroesophageal reflux
    À§½Äµµ ¿ª·ù(¼º)Áúȯ
  • disease, marble bone
    ´ë¸®¼® °ñÁúȯ
  • disease, pulseless
    ¹«¸Æ¹ÚÁúȯ
  • disease, sexually transmitted(-misible)
    ¼ºÇàÀ§Àü¿°º´, ¼ºÀμºÁúȯ, ¼ºº´
  • double vessel disease
    ÀÌÇ÷°üÁúȯ.
  • double vessel disease
    ÀÌÁß°ü»óµ¿¸ÆÁúȯ.
  • duncans disease
    ´øÄ­º´
  • duncans disease
    ´øÄ­ º´
  • dust disease
    ¸ÕÁöº´(ÊÙËÓ).
  • dyskeratosis follicularis = Dariers disease
    ¸ð³¶¼º À̰¢È­Á¾
  • encephalitis,slow virus disease
    ½½·Î¿ì ¹ÙÀÌ·¯½º º´
  • end stage renal disease, ESRD
    ¸»±â½ÅÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
PAOD peripheral arterial occlusive disease; peripheral arteriosclerotic occlusive disease
PKD polycystic kidney disease; proliferative kidney disease
PMD Pelizaeus-Merzbacher disease; posterior mandibular depth; primary myocardial disease; private medici...
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
PVD patient very disturbed; peripheral vascular disease; portal vein dilation; posterior vitreous detach...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
CAD Cold agglutinin disease
CDSC Communicable Disease Surveillance Centre
CHD Congenital Heart Disease
CERAD Consortium To Establish a Registry for Alzheimer's Disease
CAD Coronary Artery Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • virus disease
    ¹ÙÀÌ·¯½º Áúȯ
    1. ¹ÙÀÌ·¯½º´Â ¼÷ÁÖ¿¡ ħÀÔÇÏ°í ¶ÇÇÑ ¼÷ÁÖ¸¦ ÀÌ¿ëÇÏ¿© Áõ½ÄÇÔÀ¸·Î½á ÁúȯÀ» ÀÏÀ¸Å²´Ù. 2. È£Èí±â, ¼ÒÈ­±â°è, Ç¥ÇÇ-»óÇÇ, Ç츣Æä½º ¹ÙÀÌ·¯½º ÁúȯÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù.
  • volkmann's disease
    ÆúÅ©¸¸ Áúȯ
    ¼±Ãµ¼º ¹ßÀÇ ±âÇüÀ¸·Î¼­ °æÁ·±Ù°ñÀÇ Å»±¸°¡ ¿øÀÎ.
  • Von Gierke's disease
    Æù ±â¿¡¸£ÄÉ º´
  • von Willebrand disease
    von Willebrand Áúȯ
  • von Willebrand's disease
    Æù ºô¸®ºê¶õÆ® º´, Æùºô·¹ºê¶õµåº´
    ¼±Ãµ¼º À¯Àü¼º ¼ÒÁú·Î, »ó¿°»öü¼º ¿ì¼º ÇüÁú·Î À¯ÀüµÇ¸ç ÃâÇ÷ ½Ã°£ÀÇ ¿¬Àå, ÀÀ°í ÀÎÀÚ 8ÀÇ °áÇÌÀ» Ư¡À¸·Î ÇÑ´Ù. ºñ ÃâÇ÷°ú °ü·ÃÀÌ ÀÖÀ¸¸ç ¿Ü»ó ȤÀº ¼ö¼ú ÈÄÀÇ ÃâÇ÷, ¿ù°æÃâÇ÷, ºÐ¸¸ ÈÄ ÃâÇ÷ µîÀÌ ÇöÀúÈ÷ Áõ°¡ÇÑ´Ù..
  • wasting disease
    ¼Ò¸ðº´
  • weber christian disease
    ¿þ¹ö-Å©¸®½ºÂùº´
  • Weber-Christian disease °áÀý¼º, ºñÈ­³ó¼º, ÇÇÇÏ Áö¹æÁ¶Á÷ÀÇ ¿°Áõ.

    Weber-Cocayne syndrome

    ¿þ¹ö ÄÚÄÉÀÎ ÁõÈıº
    ±¹ÇѼºÀÇ Ç¥ÇÇ ¼öÆ÷Áõ.
  • Weil's disease Ȳ´Þ ÃâÇ÷¼º ·¾Å佺ÇǶóÁõ.

    Weinrich et Emmerson

    ¼è¼¼¸ðÆí¸ðÃæ
  • Werlhof disease
    º£¸¦È£ÇÁ º´
    ÇǺο¡ ÃâÇ÷À» º¼ ¼ö ÀÖ´Â Àڹݺ´ÀÇ Çϳª·Î¼­ Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´, ÃâÇ÷¼º Àڹݺ´À̶ó°íµµ ÇÑ´Ù. ÇǺγª Á¡¸·
  • wernicke's disease
    º£¸£´ÏÄɺ´
    µ¿ÀǾî=
  • whipple's disease Èí¼öºÎÀü ÁõÈıºÀ¸·Î ¼³»ç, Áö¹æ º¯Áõ, ÇǺλö¼Ò Ä§Âø, °üÀý¿°, °üÀýÅë, ¸²ÇÁÀý¿°, ÁßÃ߽Űæ°èÀå¾Ö°¡ Ư¡ÀÌ´Ù.

    Whipple's triad

    ÇÇÇþ¾ »ï¡ÈÄ
    ¿øÀο¡ °ü°è¾øÀÌ ¸ðµç ÀúÇ÷´çÁõÀÇ Æ¯Â¡À¸·Î 1
  • white finger disease
    ¹é¶øº´
    ¾ÐÃà°ø±â, ÇØ¸Ó, Àüµ¿ Åé µî ¼Õ¿¡ Áã°í Á¶ÀÛÇÏ´Â Áøµ¿°ø±¸ÀÇ Áøµ¿À¸·Î ¼ÕÀÇ µ¿¸ÆÀÌ Àå¾Ö¸¦ ¹Þ¾Æ °©Àڱ⠼հ¡¶ôÀÌ Ã¢¹éÇØÁö´Â º´. »çÁö ¸»´Ü, ƯÈ÷ ¼öÁöÀÇ Ç÷°üÀå¾Ö·Î ÁßÁõÀÏ ¶§´Â ȯºÎ°¡ ±«»ç¿¡ ºüÁö´Â Á÷¾÷º´À¸·Î ·¹À̳ë ÁõÈıºÀÇ ÇÑ º´ÇüÀ¸·Î °£ÁÖÇϰí ÀÖ´Ù. ¿øÀÎÀº Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö·Î ÀÎÇÑ µ¿¸Æ ¼öÃà ¶§¹®¿¡ ÀϾ´Â Ç÷·ù Àå¾ÖÀÌ´Ù. Áõ¼¼´Â ¹ßÀÛÀûÀ¸·Î ÀϾ ¼Õ°¡¶ôÀÌ Ã¢¹éÇØÁö¸ç, ÅëÁõ°ú Àú¸®´Â °¨ÀÌ ÀÖ°í, ÀÌ¾î º¸¶ó»öÀ¸·Î º¯Çß´Ù°¡ ºÓ¾îÁö¸é¼­ ȸº¹µÇ¸ç, ÀÌ »çÀÌ´Â ¼öºÐ ³»Áö ¼ö ½Ê ºÐÀ̰í Ãß¿ï ¶§ ¸¹´Ù. Ä¡·á´Â Ç÷°üÈ®ÀåÁ¦¸¦ »ç¿ëÇÏ°í ¼ÕÀ» Â÷Áö ¾Ê°Ô º¸¿Â¿¡ ÁÖÀÇÇϸç, °ø±¸ »ç¿ëÀº ÀÏÁ¤ ±â°£ »ï°¡´Â °ÍÀÌ ÁÁ´Ù.
  • woolsorters disease
    ¾ç¸ð¾÷ÀÚº´
    ¾ç¸ð¸¦ Ãë±ÞÇÏ´Â »ç¶÷¿¡¼­ º¼ ¼ö ÀÖ´Â ÆóÀÇ ÅºÀú·Î, B. anthrax¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Ù.
  • Zahorsky's disease
    ÀÚÈ£¸£½ºÅ° º´
    À¯¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â µ¹¹ß¼º ¹ßÁø.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
cell line <cell culture> A cell line is a permanently established cell culture that will proliferate indefinitely given appropriate fresh medium and space.
Lines differ from cell strains in that they have escaped the Hayflick limit and become immortalised. Some species, particularly rodents, give rise to lines relatively easily, whereas other species do not. No cell lines have been produced from avian tissues and the establishment of cell lines from human tissue is difficult. Many cell biologists would consider that a cell line is by definition already abnormal and that it is on the way towards becoming the culture equivalent of a neoplastic cell.
(26 Mar 1998)
cell lineage <cell culture, embryology> The lineage of a cell relates to its derivation from the undifferentiated tissues of the embryo.
Committed embryonic progenitors give rise to a range of differentiated cells: in principle it should be possible to trace the ancestry lineage) of any adult cell.
(26 Mar 1998)
cell line rights <cell culture> Ownership of a new organism entity. Rulings indicate that any organism that is patentable at all can be patented if it has been manipulated to do something useful.
Usually, the rights do not reside with the individual who has supplied the source of the organism, but with the individual or organisation who has made it.
(26 Mar 1998)
cell line, transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumour. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.
(12 Dec 1998)
cell locomotion <cell biology> Movement of a cell from one place to another.
(26 Mar 1998)
cell marker <cell biology> Biochemical or genetic characteristics which distinguish and discriminate between different cell types.
(26 Mar 1998)
cell matrix A fluid cytoplasmic substance filling the interstices of the cytoskeleton.
Synonym: cell matrix, cytomatrix.
(05 Mar 2000)
cell-mediated immunity <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody.
Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites.
(26 Mar 1998)
cell-mediated reaction Immunological reaction of the delayed type, involving chiefly T lymphocytes, important in host defense against infection, in autoimmune diseases, and in transplant rejection.
See: skin test.
(05 Mar 2000)
cell membrane <cell biology> The structure enveloping a cell, enclosing the cytoplasm and forming a selective permeability barrier.
It consists of lipids, proteins and some carbohydrates, the lipids thought to form a bilayer in which integral proteins are embedded to varying degrees.
Synonym: plasma membrane.
(26 Mar 1998)
cell membrane permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
(12 Dec 1998)
cell migration <cell biology> Implies movement of a population of cells from one place to another as in the movement of neural crest cells during morphogenesis.
(26 Mar 1998)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
cell movement <cell biology> A more general term than locomotion, that can include shape change, cytoplasmic streaming etc.
(26 Mar 1998)
cell nucleolus Within most types of eukaryotic cell nucleus, a distinct region, not delimited by a membrane, in which some species of rrna (RNA, ribosomal) are synthesised and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rrna is transcribed from a nucleolar organiser, i.e., a group of tandemly repeated chromosomal genes which encode rrna and which are transcribed by RNA polymerase I.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á